Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner

Molecular Biology Reports

Volumn 40, Issue 8, 2013, Pages 4995-5004

  Rubis, Blazej ^a   Holysz, Hanna ^a   Gladych, Marta ^a   Toton, Ewa ^a   Paszel, Anna ^a   Lisiak, Natalia ^a   Kaczmarek, Mariusz ^a   Hofmann, Johann ^b   Rybczynska, Maria ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adenocarcinoma therapy; Breast cancer; Telomerase; Telomere

Indexed keywords

CASPASE 14; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAX; SMALL INTERFERING RNA; TELOMERASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL COUNT; CELL CYCLE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNODETECTION; NGFR GENE; ONCOGENE; POLYACRYLAMIDE GEL ELECTROPHORESIS; RNA INTERFERENCE; TERC GENE; TERT GENE; TNFRSF10A GENE; TP1 GENE; UPREGULATION;

EID: 84881120080     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2600-9     Document Type: Article

References (40)

1. Cerone MA, Londono-Vallejo JA, Autexier C (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther 5:1669-1675
2. Horikawa I, Barrett JC (2003) Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24:1167-1176
3. Li AY, Lin HH, Kuo CY, Shih HM, Wang CC, Yen Y, Ann DK (2011) High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis. Mol Cell Biol 31:2605-2617
4. Papanikolaou V, Athanassiou E, Dubos S, Dimou I, Papathanasiou I, Kitsiou-Tzeli S, Kappas C, et al. (2011) hTERT regulation by NF-kappaB and c-myc in irradiated HER2-positive breast cancer cells. Int J Radiat Biol 87:609-621
5. Donate LE, Blasco MA (2011) Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci 366:76-84
6. Park KD, Seong SK, Park YM, Choi Y, Park JH, Lee SH, Baek DH, et al. (2011) Telomerase reverse transcriptase related with telomerase activity regulates tumorigenic potential of mouse embryonic stem cells. Stem Cells Dev 20:149-157
7. Sahin E, Depinho RA (2010) Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464:520-528
8. Li X, Liu Y, Wen Z, Li C, Lu H, Tian M, Jin K, et al. (2010) Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo. Mol Cancer 9:10
9. Lu Y, Gu J, Jin D, Gao Y, Yuan M (2011) Inhibition of telomerase activity by HDV ribozyme in cancers. J Exp Clin Cancer Res 30:1
10. Rahman R, Grundy R (2011) Histone deacetylase inhibition as an anticancer telomerase-targeting strategy. Int J Cancer 129(12):2765-2774
11. Wang X, Hao MW, Dong K, Lin F, Ren JH, Zhang HZ (2009) Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Arch Pharm Res 32:1263-1269
12. Bellon M, Nicot C (2008) Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst 100:98-108
13. Straat K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N, Lou F, et al. (2009) Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 101:488-497
14. Easmon J, Purstinger G, Thies KS, Heinisch G, Hofmann J (2006) Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics. J Med Chem 49:6343-6350
15. Rubis B, Krozowski Z, Trzeciak WH (2006) Arginine vasopressin stimulates 11beta-hydroxysteroid dehydrogenase type 2 expression in the mineralocorticosteroid target cells. Mol Cell Endocrinol 256:17-22
16. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15(532-534):536-537
17. Kim JH, Kim JH, Lee GE, Kim SW, Chung IK (2003) Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells. Biochem J 373:523-529
18. Rubis B, Paszel A, Kaczmarek M, Rudzinska M, Jelen H, Rybczynska M (2008) Beneficial or harmful influence of phytosterols on human cells? Br J Nutr 100:1183-1191
19. Rubis B, Polrolniczak A, Knula H, Potapinska O, Kaczmarek M, Rybczynska M (2010) Phytosterols in physiological concentrations target multidrug resistant cancer cells. Med Chem 6:184-190
20. Dong X, Liu A, Zer C, Feng J, Zhen Z, Yang M, Zhong L (2009) siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer 9:133
21. Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, Munshi NC, Goyal RK (2005) Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4:24
22. Hodges-Gallagher L, Valentine CD, El Bader S, Kushner PJ (2008) Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res Treat 109:241-250
23. Hur J, Chesnes J, Coser KR, Lee RS, Geck P, Isselbacher KJ, Shioda T (2004) The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proc Natl Acad Sci USA 101:2351-2356
24. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89:4668-4672
25. Horikawa I, Fujita K, Harris CC (2011) p53 governs telomere regulation feedback too, via TRF2. Aging (Albany NY) 3:26-32
26. Teixeira C, Reed JC, Pratt MA (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55:3902-3907
27. Yamashita H, Iwase H (2002) The role of Stat5 in estrogen receptor-positive breast cancer. Breast Cancer 9:312-318
28. Gandellini P, Folini M, Bandiera R, De Cesare M, Binda M, Veronese S, Daidone MG, et al. (2007) Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment. Biochem Pharmacol 73:1703-1714
29. Mo Y, Gan Y, Song S, Johnston J, Xiao X, Wientjes MG, Au JL (2003) Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res 63:579-585
30. Nakamura M, Masutomi K, Kyo S, Hashimoto M, Maida Y, Kanaya T, Tanaka M, et al. (2005) Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther 16:859-868
31. de Souza Nascimento P, Alves G, Fiedler W (2006) Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol Rep 16:423-428
32. Zhang PH, Zou L, Tu ZG (2006) RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res 131:143-149
33. Natarajan S, Chen Z, Wancewicz EV, Monia BP, Corey DR (2004) Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. Oligonucleotides 14:263-273
34. Xie M, Chen Q, He S, Li B, Hu C (2011) Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo. Oncol Rep 26:1019-1027
35. Kirkpatrick KL, Clark G, Ghilchick M, Newbold RF, Mokbel K (2003) hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol 29:321-326
36. Mikuła-Pietrasik J, Kuczmarska A, RubiL B, Filas V, Murias M, Zieliński P, Piwocka K, Ksia̧żek K (2012) Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms. Free Radic Biol Med 52:2234-2245
37. Zimmermann S, Glaser S, Ketteler R, Waller CF, Klingmuller U, Martens UM (2004) Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells 22:741-749
38. Gladych M, Wojtyla A, Rubis B (2011) Human telomerase expression regulation. Biochem Cell Biol 89:359-376
39. Wojtyla A, Gladych M, Rubis B (2010) Human telomerase activity regulation. Mol Biol Rep 38:3339-3349
40. Haendeler J, Drose S, Buchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, et al. (2009) Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 29:929-935